By establishing STAIN as a pathogenic mechanism in SAVI, our findings offer a conceptual advance in understanding interferonopathies and identify the STING–ZBP1–necroptosis axis as a rational and tractable target for therapeutic intervention in this otherwise treatment-refractory disease. Here, ZBP1 is linked to STING-associated vasculopathy with onset in infancy.